G. Charles Robb

2015

In 2015, G. Charles Robb earned a total compensation of $782K as Chief Financial Officer and Secretary at Corcept Therapeutics, a 123% increase compared to previous year.

Compensation breakdown

Option Awards$418,562
Salary$363,472
Total$782,034

Robb received $418.6K in option awards, accounting for 54% of the total pay in 2015.

Robb also received $363.5K in salary.

Rankings

In 2015, G. Charles Robb's compensation ranked 9,083rd out of 13,638 executives tracked by ExecPay. In other words, Robb earned more than 33.4% of executives.

ClassificationRankingPercentile
All
9,083
out of 13,638
33rd
Division
Manufacturing
3,462
out of 5,190
33rd
Major group
Chemicals And Allied Products
1,262
out of 1,854
32nd
Industry group
Drugs
1,027
out of 1,528
33rd
Industry
Pharmaceutical Preparations
801
out of 1,182
32nd
Source: SEC filing on April 21, 2017.

Robb's colleagues

We found four more compensation records of executives who worked with G. Charles Robb at Corcept Therapeutics in 2015.

2015

Joseph Belanoff

Corcept Therapeutics

Chief Executive Officer

2015

Robert Fishman

Corcept Therapeutics

Chief Medical Officer

2015

Steven Lo

Corcept Therapeutics

Former Senior Vice President, Oncology

2015

Anne LeDoux

Corcept Therapeutics

Chief Accounting Officer

News

In-depth

You may also like